Clinical Trial Update: Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 pilot study evaluating mirabegron for overactive bladder in pediatric patients has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Overactive Bladder, Urinary Incontinence | Phase 3 | Status: COMPLETED | Results posted: 2018-06-20